LifeMine Therapeutics pulls in $55 mln Series A

Boston-based LifeMine Therapeutics, a drug discovery platform provider, has raised $55 million in Series A financing. WuXi Healthcare Ventures led the round with participation from Foresite Capital, GV, Arch Ventures, Boyu Capital, Blue Pool Capital, Merck Ventures and Alexandria Venture Investments.

North AmericaUSBriefs